CRISPR and Genome Editing – Webinars and Online Events

This event will focus on the latest progress in precision genome editing, novel delivery vectors, allogeneic cell therapies and the journey from laboratory research to clinical application, offering insights into the future of personalized medicine

In this webinar, we revisit the world of synthetic biology with Professor Ron Weiss of MIT, a visionary pioneer in the field. Explore how advances in genome engineering are enabling synthetic biologists to push the boundaries of what’s possible.

In our second episode of the New Frontiers in PCR Technologies Series, join a panel of industry experts as they discuss the future of dPCR and qPCR in healthcare and research.

Whether you're focused on advancing preclinical studies or optimizing large-scale manufacturing processes, this event promises to deliver actionable insights that can drive innovation and improve outcomes in your work.

In this webinar, our expert speaker Dr. Simon Reed from Broken Strings Bioscience will discuss the background to this industry-wide challenge and the need for technological advancements in this space.

In this webinar, you’ll gain insights from experts in CGT development who will explore their experiences of CQA assays, sharing advice on how to overcome the challenges you may face in your CGT journey.

In our first episode of the New Frontiers in PCR Technology Series, join an exclusive Ask Me Anything with Professor Mikael Kubista. Discover how PCR is evolving with next-generation sequencing, CRISPR and microfluidics.

CRISPR-Cas9 gene editing is an essential functional genomics tool, facilitating the cataloging of genomic variations linked to human diseases for the discovery and validation of novel drug targets.

A major challenge when developing AAV-based therapeutics is ensuring that empty AAVs that lack therapeutic DNA are removed, increasing the efficacy of the product.

In this webinar, our expert speaker Dr. Stefano Menegatti from NC State University, will discuss his team’s approach in leveraging affinity technology to introduce new tools for purifying and characterizing biotherapeutics to match the growing demands of clinics and biotech industries worldwide.